Impact of macrolide therapy on mortality in severe sepsis caused by pneumonia

Eur Respir J. 2009 Aug;34(2):521. doi: 10.1183/09031936.00036209.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Anti-Bacterial Agents / therapeutic use*
  • Bronchiolitis / complications
  • Bronchiolitis / therapy
  • Community-Acquired Infections / complications
  • Community-Acquired Infections / drug therapy
  • Community-Acquired Infections / mortality
  • Critical Care
  • Cystic Fibrosis / complications
  • Cystic Fibrosis / therapy
  • Humans
  • Inflammation
  • Macrolides / therapeutic use*
  • Pneumonia / complications*
  • Pneumonia / drug therapy
  • Pneumonia / mortality
  • Randomized Controlled Trials as Topic
  • Sepsis / drug therapy*
  • Sepsis / etiology
  • Sepsis / mortality*
  • Treatment Outcome
  • beta-Lactams / therapeutic use

Substances

  • Anti-Bacterial Agents
  • Macrolides
  • beta-Lactams